[Other] Lenalidomide Plus Rituximab for Relapsed/Refractory Indolent Non-Hodgkin Lymphoma: 5-Year Follow-Up and Subgroup Analyses From the Phase III AUGMENT Trial |
|
This post will be closed automatically in 2026-09-18 03:09
Reward20points
|
30
Safety Effectiveness of Rectangular Rapid Flashing Beacons Pedestrian Enhancement
10
Efficacy and safety of oral orforglipron in patients with type 2 diabetes: a multicentre, randomised, dose-response, phase 2 study"
20
Motivation and the Goal Theory of Current Concerns
20
Interaction of gas molecules with cyclo[N]carbon: Size dependence and atomic doping modulation
20
Fossil evidence favors a role for vision in the modular evolution of the primate neocortex
